Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.5 USD | +8.70% | -24.62% | -79.17% |
05-16 | AEON Biopharma, Inc. Announces Termination of Peter Reynolds as Chief Financial Officer, Effective May 17, 2024 | CI |
05-16 | AEON Biopharma, Inc. Announces Executive Changes | CI |
- Stock Market
- Equities
- AEON Stock
- News AEON Biopharma, Inc.
- MarketScreener Strategies